• About Us
    • Fact Checking Policy
    • Ownership & funding information
    • Volunteer
  • Subscribe
  • Letter submission
    • Submissions Policy
  • Contact Us
The Online Citizen Asia
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
The Online Citizen Asia
No Result
View All Result

Alaska healthcare worker had severe allergic reaction after getting Pfizer-BioNTech COVID-19 vaccine

She did not have a history of allergic reactions

by Aldgra F.
17/12/2020
in Health, International
Reading Time: 4 mins read
3

A healthcare worker at the Bartlett Regional Hospital in Juneau, Alaska, has reportedly developed a severe allergic reaction after getting the Pfizer-BioNTech COVID-19 vaccine on Tuesday (15 Dec) despite not having a history of allergic reactions.

The middle-aged woman had to be hospitalised overnight for observation due to the symptoms, as reported by NBC.

Dr Lindy Jones, the emergency physician who treated the woman, said on Wednesday (16 Dec) that the woman had no history of allergies, but she had an anaphylactic reaction about 10 minutes after receiving the vaccine.

Her reactions include feeling flushed and shortness of breath.

“She had a red, flushed rash over her face and torso,” said the physician.

Dr Jones noted that the patient’s symptoms subsided for a while but then re-emerged, adding that the symptoms resolved after being administered with allergy treatment epinephrine.

The woman’s reaction is believed to be similar to the two cases of anaphylaxis reported in Britain last week.

Following the two reports, the Medicines and Healthcare Products Regulatory Agency (MHRA) warned that anyone with a history of anaphylaxis to medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine.

“Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine,” said June Raine, chief executive of the MHRA.

“A second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine,” she added.

The Pfizer-BioNTech vaccine has already received conditional approvals or emergency authorisations from four regulatory agencies, including the UK’s Medicines and Healthcare products Agency (MHRA), Health Canada, the US’ Food and Drug Administration (FDA), and Singapore’s Health Sciences Authority (HSA).

Meanwhile, the European Medicines Agency’s (EMA) Human Medicines Committee (CHMP) has set a date for the Pfizer-BioNTech COVID-19 vaccine assessment meeting, which set to be scheduled on 21 December, following the data it received from the company and its pending evaluation outcome.

“The CHMP will conclude its assessment at the earliest possible timepoint and only once the data on the quality, safety and effectiveness of the vaccine are sufficiently robust and complete to determine whether the vaccine’s benefits outweigh its risks,” it asserted.

S’pore expects delivery of Pfizer-BioNTech vaccine by December-end

Over in Singapore, the HSA has recently granted an authorisation for the Pfizer-BioNTech COVID-19 vaccine to be used in the city-state, with the first shipment due to arrive in Singapore by the end of December.

“HSA’s review of the available clinical data found that the benefits of the Pfizer-BioNTech COVID-19 vaccine outweigh the known risks. The vaccine demonstrated a high vaccine efficacy of 95%,” it said in a statement on Monday (14 Dec).

The vaccine was granted interim authorisation under the Pandemic Special Access Route (PSAR), which facilitates access to critical novel vaccines, medicines and medical devices during a pandemic, said HSA.

“Using PSAR, HSA can start evaluating new vaccines, medicines and medical devices from the early stages of clinical studies, as and when real-time data is submitted by companies on a ‘rolling’, or staggered basis, instead of waiting for the full data set to be submitted before starting our evaluation,” it added.

Citing the vaccination regime submitted by Pfizer-BioNTech, HSA said two doses are required to be administered 21 days apart, in people aged 16 years and above.

“Pregnant women, immunocompromised persons and those under the age of 16 should also not receive the Pfizer-BioNTech vaccine as the safety and efficacy data on this group of persons is not available yet,” it stated.

Additionally, people with a history of anaphylaxis or the rapid onset of severe allergic reactions should not receive the Pfizer-BioNTech vaccine as a precautionary measure.

Noting that the safety profile of the vaccine is “generally consistent” with other registered vaccines, HSA explained that some people may experience side effects such as pain, redness, swelling at the injection site, as well as fatigue, headache and muscle ache after vaccination.

While not everyone will experience these side effects, they are “common and expected” as part of the body’s natural response to build immunity against the COVID-19, it further noted.

Update: Another healthcare worker from Alaska suffers allergic reaction to Pfizer-BioNTech vaccine

A second healthcare worker, a male, has reportedly suffered an allergic reaction 10 minutes after getting the Pfizer-BioNTech vaccine at Bartlett Regional Hospital on Wednesday (16 Dec).

Bartlett hospital said in a statement that the man experienced “eye puffiness, lightheadedness, and scratchy throat” but it was not considered as anaphylaxis, as reported by CNN.

He was treated in the emergency department with epinephrine, Pepcid and Benadryl, according to the hospital.

It added that the worker felt “completely back to normal within an hour and was released.”

“Both incidents were reported to the CDC’s [Centers for Disease Control and Prevention] Vaccine Adverse Event Reporting System (VAERS) database. Bartlett Regional Hospital and the State of Alaska Department of Health and Social Services are in close communications with the CDC, and the agency is providing guidance and support,” said the hospital.

For just US$7.50 a month, sign up as a subscriber on The Online Citizen Asia (and enjoy ads-free experience on our site) to support our mission to transform TOC into an alternative mainstream press.
Tags: COVID-19Pfizer-BioNTech

Related Posts

Zero-COVID left in dust as Chinese revellers fuel travel boom
AFP

Zero-COVID left in dust as Chinese revellers fuel travel boom

19/01/2023
China ends quarantine for overseas travellers after years of self-imposed isolation
AFP

China back to ‘normal’ after end of COVID curbs: official

17/01/2023
UK health firm estimates 9,000 COVID deaths in China per day but Chinese govt says only 10 since 7 Dec
AFP

‘Not necessary’ to dwell on COVID death tally, Chinese experts say

11/01/2023
South Korea imposes restrictions on travellers from China over COVID surge
AFP

China scraps visa-free transit for South Koreans and Japanese over COVID curbs

11/01/2023
‘Total mess’ in China’s rural east as COVID wave hits hard
AFP

‘Total mess’ in China’s rural east as COVID wave hits hard

11/01/2023
China halts short-term visas for Japanese over COVID travel curbs
AFP

China halts short-term visas for Japanese over COVID travel curbs

10/01/2023
Subscribe
Connect withD
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Notify of
Connect withD
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
3 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

Latest posts

457 civil society organizations call on ASEAN to move beyond the Five-Point Consensus

Myanmar junta sets out tough new rules for political parties

27/01/2023
Thai ruling party names deputy PM as main election candidate

Thai ruling party names deputy PM as main election candidate

27/01/2023
Mrs Teo says SG continues to invest in training local talent while MNCs transfer staff to work in SG

Mrs Teo says SG continues to invest in training local talent while MNCs transfer staff to work in SG

27/01/2023
One third of Amazon ‘degraded’ by human activity, drought: study

One third of Amazon ‘degraded’ by human activity, drought: study

27/01/2023
Luxembourg court sets aside Sulu heirs’ attachment order to enforce US$15b claim against Malaysia

Luxembourg court sets aside Sulu heirs’ attachment order to enforce US$15b claim against Malaysia

27/01/2023
Philippines to appeal ICC resumption of drug war probe

Philippines to appeal ICC resumption of drug war probe

27/01/2023

ASEAN governments must stop using ‘lawfare’ against critics, Southeast Asian MPs say

27/01/2023
Low Yen Ling says MTI and MAS don’t expect persistent inflation but they now say inflation projected to “stay elevated”

Low Yen Ling says MTI and MAS don’t expect persistent inflation but they now say inflation projected to “stay elevated”

27/01/2023

Trending posts

Two Indian nationals paid about S$330 and S$730 respectively for forged certificates submitted in their S-Pass application

MOM found issuing EPs meant for foreign PMETs to PRC waitress and general worker

by Correspondent
26/01/2023
32

...

Ho Ching breaks silence over Temasek’s write down of its US$275 million investment in FTX, says it “can afford to be contrarian”

US regulator questions VCs’ due diligence work prior to investing in FTX; Ho Ching says Temasek can afford to be contrarian

by The Online Citizen
24/01/2023
28

...

Indian rupee falls 60% since signing of CECA while Singapore becomes top investor in India

by Correspondent
25/01/2023
49

...

Alaska healthcare worker had severe allergic reaction after getting Pfizer-BioNTech COVID-19 vaccine

by Aldgra F.
17/12/2020
3

...

“党籍不会过期失效”  前进党称已就党籍终止知会卡拉

AGC asked to explain purposes of 68 private letters of inmates illegitimately forwarded to prosecutors

by The Online Citizen
21/01/2023
16

...

Temasek and GIC reportedly in talks with Adani Group accused of “brazen” market manipulation and accounting fraud

Temasek and GIC reportedly in talks with Adani Group accused of “brazen” market manipulation and accounting fraud

by The Online Citizen
26/01/2023
32

...

December 2020
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Nov   Jan »
  • About Us
  • Subscribe
  • Letter submission
  • Contact Us

© 2006 - 2021 The Online Citizen

No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
  • Subscribers login

© 2006 - 2021 The Online Citizen

wpDiscuz